VSTM · Verastem, Inc. · Insider Trading
Substantial doubt about the company's ability to continue as a going concern.
“However, given the risks associated with these potential strategic or financing opportunities, they are not deemed probable for purposes of the going concern assessment and do not alleviate the substantial doubt about our ability to continue as a going concern. There can be no assurance that we will be able to generate sufficient net product revenues or obtain additional capital on favorable terms or at all.”View the 10-Q filed Aug 6, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-03 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
1,302 |
| 2026-06-22 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
20,871 |
| 2026-06-22 | Calkins Daniel |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
4,032 |
| 2026-06-22 | Calkins Daniel |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
57 |
| 2026-05-21 | BAILEY MICHAEL P |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
36,000 restricted stock units granted to the Reporting Person as an annual grant under the Issuer's Amended and Restated 2021 Equity Incentive Plan ("Annual Grant RSUs"). Each Annual Grant RSU represents the contingent right to receive one share of Common Stock. The Annual Grant RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. 72,000 restricted stock units granted to the Reporting Person as an initial grant under the Issuer's Amended and Restated 2021 Equity Incentive Plan ("Initial Grant RSUs"). Each Initial Grant RSU represents the contingent right to receive one share of Common Stock. The Initial Grant RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest) on each quarterly anniversary of May 21, 2026 (the "Start Date") until the award is fully vested on the date that is three (3) years from the Start Date, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
108,000 |
| 2026-05-21 | Stuglik Brian M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
36,000 |
| 2026-05-21 | Tollefson Karin Anna |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
36,000 |
| 2026-05-21 | JOHNSON JOHN |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
36,000 |
| 2026-05-21 | Rowinsky Eric K |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
36,000 |
| 2026-05-21 | Kapur Anil |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
36,000 |
| 2026-05-21 | ROBERTSON MICHELLE |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
36,000 |
| 2026-05-21 | Bunn Paul A. |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
RSUs granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest in twelve substantially equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion shall vest). The first eleven installments shall vest beginning on the last day of each month over a period from June, 2026 to April, 2027 and the last installment shall vest on the earlier of (i) the day before the 2027 Annual Meeting of Stockholders is held or (ii) May 31, 2027, provided that the Reporting Person continues to serve as a director of the Issuer on each such vesting date. |
Common Stock
|
36,000 |
| 2026-05-04 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
806 |
| 2026-03-20 | Calkins Daniel |
Chief Financial Officer |
Award↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
57 |
| 2026-02-04 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
970 |
| 2026-01-21 | Paterson Dan |
Director, President and CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 33.3% of the RSUs on the first three anniversaries of January 21, 2026 such that the award is fully vested on January 21, 2029 (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. |
Common Stock
|
213,785 |
| 2026-01-21 | Calkins Daniel |
Chief Financial Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Restricted stock units ("RSUs") granted to the Reporting Person under the Issuer's Amended and Restated 2021 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of Common Stock. The RSUs vest as to 33.3% of the RSUs on the first three anniversaries of January 21, 2026 such that the award is fully vested on January 21, 2029 (with the number of RSUs vesting on each vesting date rounded down to the nearest whole RSU, except with respect to the final vesting date on which all remaining unvested RSUs shall vest), provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. |
Common Stock
|
16,665 |
| 2026-01-12 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
10,321 |
| 2026-01-12 | Calkins Daniel |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
5,039 |
| 2026-01-06 | Kauffman Michael |
Director, President of Development |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
The stock option vests 33.33% of the shares on the first anniversary of January 6, 2026 (the "Grant Date"), and an additional 8.33% will vest at the end of each successive three-month period following the first anniversary of the Grant Date until the third anniversary of the Grant Date (with the number of shares vesting on each vesting date rounded down to the nearest whole share, except with respect to the final vesting date on which all remaining unvested shares shall vest) provided that the Reporting Person continues to serve as an employee of or other service provider to the Issuer on each such vesting date. |
Stock Option (right to buy)
|
200,000 |
| 2025-12-24 | Calkins Daniel |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
80 |
| 2025-12-16 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
393 |
| 2025-12-16 | Gagnon Robert E. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
283 |
| 2025-12-16 | Stuglik Brian M |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
592 |
| 2025-12-11 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-10 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-09 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-08 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-05 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-04 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-03 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-02 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-12-01 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-11-28 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-11-26 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-11-25 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-11-24 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-11-21 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-11-21 | Bunn Paul A. |
Director |
Convert↓
Filing footnotes — Stock Options (right to buy) (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The stock option vested in twelve equal installments (rounded down to the nearest whole share on each vesting date except with respect to the final vesting date on which the remaining unvested portion vested). The first eleven installments vested beginning on the last day of the month over the period from June, 2024 to April, 2025 and the last installment vested on the day before the 2025 Annual Meeting of Stockholders. |
Stock Options (right to buy)
|
6,250 |
| 2025-11-21 | Kauffman Michael |
Director, President of Development |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 through $10.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. |
Common Stock
|
8,550 |
| 2025-11-21 | Bunn Paul A. |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
6,250 |
| 2025-11-21 | Bunn Paul A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $10.00 through $10.01, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. |
Common Stock
|
6,250 |
| 2025-11-03 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. |
Common Stock
|
2,000 |
| 2025-11-03 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
1,299 |
| 2025-10-09 | Bunn Paul A. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.70 through $9.33, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth herein. |
Common Stock
|
8,333 |
| 2025-09-24 | Calkins Daniel |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
25 |
| 2025-09-22 | Calkins Daniel |
Chief Financial Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
57 |
| 2025-09-16 | Paterson Dan |
Director, President and CEO |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
390 |
| 2025-09-16 | Stuglik Brian M |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
587 |
| 2025-09-16 | Gagnon Robert E. |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported on this Form 4 represents shares sold by the Reporting Person to satisfy statutory withholding requirements in connection with the vesting of restricted stock units. |
Common Stock
|
281 |